Kodiak Sciences Inc.
KOD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001468748
In the last 90 days, Kodiak Sciences Inc. insiders filed 3 open-market purchases and 0 sales; 200 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Kodiak Sciences Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 131 | 143 | +12 |
| Shares | 41.1M | 42.0M | +901.4K (+2.2%) |
| Value | $313.1M | $324.6M | +$11.4M (+3.7%) |
New holders (23)
Institutions that held Kodiak Sciences Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (11)
Institutions that held Kodiak Sciences Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 541,400 | $4.14M |
| HRT Financial LP | 62,690 | $478.0K |
| NinePointTwo Capital | 56,642 | $432.0K |
| Simplex Trading, LLC | 17,748 | $135.0K |
| Walleye Capital LLC | 16,389 | $125.0K |
| Bayesian Capital Management, LP | 12,439 | $95.0K |
| Tudor Investment Corp Et Al | 11,181 | $85.0K |
| Raymond James & Associates | 11,155 | $85.0K |
| Tiedemann Advisors, LLC | 10,000 | $76.0K |
| Umb Bank N A | 71 | $1.00K |
| Captrust Financial Advisors | 47 | $0 |